In conjunction with reports that documented aberrant nuclear retention of HDAC4 in cellular and animal models of Parkinson’s disease and Ataxia telangiectasia32,33, our results also imply that class IIa HDACs may exert their effects via different mechanisms under the physiological and pathological conditions depending on kinetics of nuclear import/export. Here, HDAC4 is linked to Parkinson disease.